From: The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer
Variables
Median survial time (month)
1-year survial rate (%)
Negative
Positive
MMP-9
11
59.3%
32.2%
TN-C
54.4%
34.1%
fTN-C
10
58.4%
29.7%
MMP-9+TN-C
9
59.4%
20.4%